Class C medical devices are considered moderate-to-high risk and must comply with Vietnam’s Ministry of Health (MOH) regulations, particularly Circular 39/2016/TT-BYT under the ASEAN Medical Device Directive (AMDD). Below are the key requirements for registration:
If the manufacturer is not based in Vietnam, a Local Authorized Representative (LAR) must be appointed.
The LAR must be a legally registered company in Vietnam with authorization to distribute medical devices.
The LAR will submit the application, communicate with MOH, and ensure post-market compliance.
✅ Application Form – Filled and signed by the LAR.
✅ Letter of Authorization (LOA) – From the manufacturer to the LAR.
✅ Certificate of Free Sale (CFS) or Market Authorization – Issued by the country of origin or recognized regulatory authorities (e.g., FDA, CE, TGA).
✅ ISO 13485 Certificate – Proof of Quality Management System (QMS) compliance.
✅ Device Description – Including name, model, intended use, and working principle.
✅ Risk Classification Justification – Explaining why the device is classified as Class C according to Vietnam’s classification rules.
✅ Instructions for Use (IFU) – Must be translated into Vietnamese.
✅ Labeling Information – Must comply with Vietnamese regulations (Vietnamese language required).
✅ Clinical Evaluation Report – Required for certain Class C devices.
✅ Test Reports – Performance and safety testing based on recognized standards (e.g., IEC, ISO).
✅ Declaration of Conformity – Compliance with ASEAN AMDD and relevant international standards.
✅ Post-Market Surveillance Plan – Outlining monitoring, adverse event reporting, and recall procedures.
Submit the application and supporting documents online through the MOH DMEC portal: https://dmec.moh.gov.vn.
Pay the registration fee as per MOH regulations.
MOH will review the dossier for completeness and compliance.
Technical evaluation may be required, depending on the device type.
If approved, MOH will issue a Marketing Authorization (MA) number.
Once registered, the device must comply with:
✅ Post-market surveillance – Reporting of adverse events.
✅ Proper labeling and distribution requirements.
✅ Renewal or updates if any significant changes occur.
.jpg)